BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23504291)

  • 1. Low ING4 protein expression detected by paraffin-section immunohistochemistry is associated with poor prognosis in untreated patients with gastrointestinal stromal tumors.
    Nanding A; Tang L; Cai L; Chen H; Geng J; Liu X; Ning X; Li X; Zhang Q
    Gastric Cancer; 2014 Jan; 17(1):87-96. PubMed ID: 23504291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of ING4 expression on gastric gastrointestinal stromal tumors by immunohistochemistry.
    Sahin S; Ekinci O; Seckin S; Dursun A
    Ann Ital Chir; 2017; 88():311-317. PubMed ID: 28566557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
    Basilio-de-Oliveira RP; Pannain VL
    World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach.
    Fujita A; Yamamoto H; Imamura M; Nakamura N; Maehara Y; Tsuneyoshi M; Oda Y
    Virchows Arch; 2012 Feb; 460(2):163-9. PubMed ID: 22190007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors.
    Jiang J; Jin MS; Suo J; Wang YP; He L; Cao XY
    World J Gastroenterol; 2012 May; 18(20):2569-75. PubMed ID: 22654456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors.
    Belev B; Brčić I; Prejac J; Golubić ZA; Vrbanec D; Božikov J; Alerić I; Boban M; Razumović JJ
    World J Gastroenterol; 2013 Jan; 19(4):523-7. PubMed ID: 23382631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A correlation research of Ki67 index, CT features, and risk stratification in gastrointestinal stromal tumor.
    Li H; Ren G; Cai R; Chen J; Wu X; Zhao J
    Cancer Med; 2018 Sep; 7(9):4467-4474. PubMed ID: 30123969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of fatty acid-binding protein-4 in gastrointestinal stromal tumors and its significance for prognosis.
    Zang WJ; Wang ZN; Hu YL; Huang H; Ma P
    J Clin Lab Anal; 2021 Nov; 35(11):e24017. PubMed ID: 34558731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.
    Fang F; Luo LB; Tao YM; Wu F; Yang LY
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):409-16. PubMed ID: 19208663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and clinicopathological significance of CD9 in gastrointestinal stromal tumor.
    Yang H; Shen C; Zhang B; Chen H; Chen Z; Chen J
    J Korean Med Sci; 2013 Oct; 28(10):1443-8. PubMed ID: 24133347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Fatty Acid-Binding Protein-3 in Gastrointestinal Stromal Tumors and Its Significance for Prognosis.
    Chen X; Hu SL; Feng Y; Li P; Mao QS; Xue WJ
    J Surg Res; 2021 Apr; 260():462-466. PubMed ID: 33272594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of gastrointestinal bleeding and expression of PTEN and Ki-67 on primary gastrointestinal stromal tumors.
    Wang H; Chen P; Liu XX; Zhao W; Shi L; Gu XW; Zhu CR; Zhu HH; Zong L
    World J Surg Oncol; 2014 Apr; 12():89. PubMed ID: 24712384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Ki67 Index in Endoscopic Ultrasound-Guided Fine Needle Aspiration Samples for the Assessment of Malignancy Risk in Gastric Gastrointestinal Stromal Tumors.
    Seven G; Kochan K; Caglar E; Kiremitci S; Koker IH; Senturk H
    Dig Dis; 2021; 39(4):407-414. PubMed ID: 33017820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal stromal tumors - quantitative detection of the Ki-67, TPX2, TOP2A, and hTERT telomerase subunit mRNA levels to determine proliferation activity and a potential for aggressive biological behavior.
    Kalfusova A; Hilska I; Krskova L; Kalinova M; Linke Z; Kodet R
    Neoplasma; 2016; 63(3):484-92. PubMed ID: 26952515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of carbonic anhydrase II and Ki-67 proteins in prognosis of gastrointestinal stromal tumors.
    Liu LC; Xu WT; Wu X; Zhao P; Lv YL; Chen L
    World J Gastroenterol; 2013 Apr; 19(16):2473-80. PubMed ID: 23674848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exon 11 mutations, Ki67, and p16(INK4A) as predictors of prognosis in patients with GIST.
    Cerski MR; Pereira F; Matte US; Oliveira FH; Crusius FL; Waengertner LE; Osvaldt A; Fornari F; Meurer L
    Pathol Res Pract; 2011 Nov; 207(11):701-6. PubMed ID: 22024151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.
    Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY
    Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
    Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
    Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A4 expression is associated with poor prognosis in patients with resectable gastrointestinal stromal tumor.
    Shen W; Tan X; Hao F
    Libyan J Med; 2019 Dec; 14(1):1659669. PubMed ID: 31474194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis.
    Ichikawa H; Yoshida A; Kanda T; Kosugi S; Ishikawa T; Hanyu T; Taguchi T; Sakumoto M; Katai H; Kawai A; Wakai T; Kondo T
    Cancer Sci; 2015 Jan; 106(1):115-24. PubMed ID: 25457157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.